Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2006; 12(2): 292-297
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.292
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.292
Medication | No of patients (%) | ||
UC | Prednisone | 12/37 | 32 |
AZA | 11/37 | 30 | |
ASA | 8/37 | 22 | |
Ciclosporine | 4/37 | 11 | |
No medication | 12/37 | 32 | |
Any immunomodulating drug | 20/37 | 54 | |
CD | Prednisone | 6/24 | 25 |
AZA | 5/24 | 21 | |
ASA | 2/24 | 8 | |
Ciproxin | 1/24 | 4 | |
Anti-TNF | 2/24 | 8 | |
No medication | 13/24 | 54 | |
Any immunomodulating drug | 10/24 | 42 |
-
Citation: Mallant-Hent R, Mooij M, Blomberg BV, Linskens R, Bodegraven AV, Savelkoul P. Correlation between
Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBD. World J Gastroenterol 2006; 12(2): 292-297 - URL: https://www.wjgnet.com/1007-9327/full/v12/i2/292.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i2.292